Animas Corporation Report issue

For profit
Founded: West Chester PA United States (1996)
Status: Acquired by Johnson and Johnson (2005)

Organization Overview

First Clinical Trial
2008
NCT00922649
First Marketed Drug
1996
urea
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ANIMA | Animas Corporation

Active Ingredients

Marketed Drugs (8)

betamethasone (celestone) (1985)

codeine (Phenergan) (1985)

cyclophosphamide (cytoxan) (2018)

dexamethasone (1976)

hydroxyzine (vistaril) (1980)

pseudoephedrine (Benylin) (1985)

triprolidine (Actidil) (1985)

urea (1976)

Drugs in Other Trials (1)

insulin human (humulin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1